Abbott Laboratories has reported sales of $10.6bn for the third quarter (Q3) of 2024, as against $10.4bn in Q2 2024, with ...

Robert Ford’s comments come as new CGMs and insulin pumps continue to roll out in the diabetes tech space, including over-the-counter glucose sensors.

Normoglycemic individuals spent 87% of their daily time in in the “tight range” of glucose levels (70-140 mg/dL) and the remainder above 140 mg/dL.

Experts reevaluate coverage policies and the financial impact of antiobesity medications based on updated clinical data and ...

Not everyone in the health field is so bullish on the prospects of CGMs for everyone, and question whether digging in too ...

The Syringa Hospital and Clinics Diabetes Support group meets from 3-4 p.m. at the Soltman Center on the following dates with the topics listed: ...

Breakthrough stem cell transplants for diabetes have allowed patients to produce their own insulin, offering hope for a ...

A 10-year-old boy from New Town has been living life to the fullest despite his recent diagnosis of Type 1 diabetes.

To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that ...

Renee Rucinsky, DVM, DABVP, discussed insulin therapy and SGLT2 inhibitors in her lecture at the Fetch dvm360 conference in Atlantic City ...

It’s well known that diet and exercise is important, but many people may not know how managing glucose levels can significantly enhance overall health and well-being. Nutrition expert, ...

With an in-line performance expected in Q3, ABT stock may trade sideways next week. However, we would watch out for its ...